Amanda Guisbond

Amanda Guisbond is a seasoned communications professional with extensive experience in the healthcare, science, and technology sectors. Currently serving as Founder and Chief Communicator at Intersection: Health since October 2022, Amanda provides strategic communications and content development for brands and leaders. Amanda also advises Stillmind Therapeutics on developing precision medicines for brain disorders. Previous roles include VP of Marketing at BioSymetrics, Head of Communications at Recursion, and Director of Corporate Communications at Amwell. Amanda's expertise spans corporate branding, media relations, and digital strategy, with a strong track record of working with high-profile clients such as Moderna, Sword Health, and several biopharma startups. Amanda holds both a B.A. and M.S. in Communications from Clark University.